{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:21Z","timestamp":1787841321378,"version":"build-2784847793"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:p>\n                    Urticaria, a perplexing disease of ever-changing explanations, is being renovated almost everyday by newer facts and findings accumulated from different parts of the globe. Cost of the urticaria treatment gradually grows higher and higher whereas the ailment disturbs the quality of life very adversely. Disorder of coagulation cascade has recently thrown some new light into its mechanism. Non-allergic angioedema induced by bradykinin caused by genetic defects and ACE-inhibitors has also been noted. Role of\n                    <jats:italic toggle=\"yes\">H. pylori<\/jats:italic>\n                    in the pathogenesis of urticaria has also been re-reviewed. Urticaria could sometimes mimic erythema multiforme and is termed urticaria multiforme. Skin biopsy showed features of vasculitis in good number of urticaria irrespective of clinical features. Contact sensitization showed positive results in certain cases thus proving contact urticaria. Topical clobetasol, systemic omalizumab and NB UVB have shown promising results in certain forms of urticaria.\n                  <\/jats:p>","DOI":"10.4103\/0019-5154.55642","type":"journal-article","created":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T06:30:03Z","timestamp":1252564203000},"page":"280-282","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["WHAT\u2032S NEW IN URTICARIA?"],"prefix":"10.4103","volume":"54","author":[{"given":"Sanjay","family":"Ghosh","sequence":"first","affiliation":[{"name":"Urticaria Clinic, Institute of Allergic and Immunological Skin Diseases, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250920","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2340\/00015555-0240","article-title":"Urticaria: Current opinions about etiology, diagnosis and therapy","volume":"87","author":"Zuberbier","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"R2-20250920","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archdermatol.2007.5","article-title":"Annual direct and indirect health care costs of chronic idiopathic urticaria: A cost analysis of 50 nonimmunosuppressed patients","volume":"144","author":"Delong","year":"2008","journal-title":"Arch Dermatol"},{"key":"R3-20250920","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1081-1206(10)60208-6","article-title":"Increasing hospitalizations due to angioedema in the United States","volume":"101","author":"Lin","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R4-20250920","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2007.02324.x","article-title":"The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria","volume":"22","author":"Engin","year":"2008","journal-title":"Eur Acad Dermatol Venereol"},{"key":"R5-20250920","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.autrev.2007.08.002","article-title":"Chronic urticaria: A disease at a crossroad between autoimmunity and coagulation","volume":"7","author":"Asero","year":"2007","journal-title":"Autoimmun"},{"key":"R6-20250920","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1398-9995.2007.01427.x","article-title":"Nonallergic angioedema: Role of bradykinin","volume":"62","author":"Bas","year":"2007","journal-title":"Allergy"},{"key":"R7-20250920","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1468-3083.2007.02353.x","article-title":"Association of insertion\/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response","volume":"22","author":"Akcali","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R8-20250920","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1523-5378.2007.00522.x","article-title":"Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test","volume":"12","author":"Magen","year":"2007","journal-title":"Helicobacter"},{"key":"R9-20250920","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0019-5359.40579","article-title":"Chronic urticaria and Helicobacter pylori","volume":"62","author":"Yadav","year":"2008","journal-title":"Indian J Med Sci"},{"key":"R10-20250920","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1542\/peds.2006-1553","article-title":"\"Urticaria multiforme\": A case series and review of acute annular urticarial hypersensitivity syndromes in children","volume":"119","author":"Shah","year":"2007","journal-title":"Pediatrics"},{"key":"R11-20250920","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2230.2008.02891.x","article-title":"A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: A retrospective study of 47 patients","volume":"34","author":"Tosoni","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R12-20250920","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaad.2006.07.023","article-title":"Role of contact sensitization in chronic urticaria","volume":"56","author":"Guerra","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R13-20250920","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2133.2005.06986.x","article-title":"Clobetasol propionate 0.05% in a novel foam formulation (CF) is safe and effective in the short-term treatment of patients with delayed pressure urticaria: A randomized, double-blind, placebo-controlled trial","volume":"154","author":"Vena","year":"2006","journal-title":"Br J Dermatol"},{"key":"R14-20250920","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60644-8","article-title":"Effect of omalizumab on patients with chronic urticaria","volume":"99","author":"Spector","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R15-20250920","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2340\/00015555-0434","article-title":"Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: A randomized controlled trial","volume":"88","author":"Engin","year":"2008","journal-title":"Acta Derm Venereol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00076423-200954030-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:48:46Z","timestamp":1787838526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00076423-200954030-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.4103\/0019-5154.55642","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"2009-04-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-05-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}